Childhood exposure to second-hand smoke (SHS) and risk of breast cancer in postmenopausal never smokers: the Multiethnic Cohort (MEC) study [0.03%]
儿童时期接触环境烟草烟雾与绝经后从不吸烟女性乳腺癌发病风险的关联：族裔流行病学队列研究（MEC）的一项分析
Inger T Gram,Song-Yi Park,Lynne R Wilkens et al.
Inger T Gram et al.
Integrated transcriptome study reveals a stress response state CD4 +T cells related to immune tolerance in breast cancer [0.03%]
整合转录组研究揭示乳腺癌相关免疫耐受的CD4+t细胞应激反应状态
Jinyuan Gu,Qi Qi,Xinrui Mao et al.
Jinyuan Gu et al.
The significance of molecular heterogeneity in breast cancer batch correction and dataset integration [0.03%]
分子异质性在乳腺癌批次效应校正和数据集整合中的意义
Nicholas Moir,Dominic A Pearce,Simon P Langdon et al.
Nicholas Moir et al.
Background: Breast cancer research benefits from a substantial collection of gene expression datasets that are commonly integrated for subsequent computational analysis. Gene expression batch effects arising between exper...
Efficacy of everolimus in patients with hormone receptor positive, HER2 negative, metastatic breast cancer pretreated with CDK4/6 inhibitors [0.03%]
依维莫司治疗经CDK4/6抑制剂治疗后的激素受体阳性、HER2阴性转移性乳腺癌患者的疗效研究
Justine Dutheil,Victor Pereira,Cyril Boisson et al.
Justine Dutheil et al.
Context and aims: Everolimus was approved in 2012 for the treatment of advanced hormone-receptor-positive, HER2-negative metastatic breast cancer (MBC) in combination with exemestane. Since then, the first line treatment ...
Multicenter Study
Breast cancer research : BCR. 2025 Dec 24;27(1):220. DOI:10.1186/s13058-025-02109-3 2025
Computational decoding of cell-cycle phase effects on cancer hallmarks across breast cancer subtypes [0.03%]
基于乳腺癌亚型的细胞周期阶段对癌症标志物的计算解码研究
Miguel Castresana-Aguirre,Alexios Matikas,Linda S Lindström et al.
Miguel Castresana-Aguirre et al.
Retraction Note: Epidermal growth factor-receptor activation modulates Src-dependent resistance to lapatinib in breast cancer models [0.03%]
撤回 notice:表皮生长因子-受体活化调节乳腺癌模型中拉帕替尼的Src依赖性抗药性
Luigi Formisano,Lucia Nappi,Roberta Rosa et al.
Luigi Formisano et al.
PAK2 promotes CTC cluster formation by phosphorylating E-cadherin to enhance cell-cell adhesion in breast cancer [0.03%]
PAK2通过磷酸化E-钙黏着蛋白促进乳腺癌细胞间粘附以形成CTC簇
Lihuang Guo,Jiancheng Li,Wenxing Zhu et al.
Lihuang Guo et al.
Background: Circulating tumor cell (CTC) clusters exhibit significantly greater metastatic potential than single CTCs and are associated with poorer overall survival in cancers. However, the molecular mechanisms driving C...
Imlunestrant, an oral selective estrogen receptor degrader, in combination with HER2 directed therapy, with or without abemaciclib, in ER-positive, HER2-positive advanced breast cancer: results from the phase 1a/1b EMBER study [0.03%]
一种口服选择性雌激素受体降解剂Imlunestrant联合HER2靶向疗法，加或不加Abemaciclib，在ER阳性、HER2阳性晚期乳腺癌中的应用：EMBER一期临床研究的结果
Manali Bhave,Komal L Jhaveri,Peter A Kaufman et al.
Manali Bhave et al.
Neutrophils matter: new clinical insights on their role in the progression of metastatic breast cancer [0.03%]
中性粒细胞很重要：其在转移性乳腺癌进展中的作用的新临床见解
Bruna F Correia,Daniela Grosa,Rute Salvador et al.
Bruna F Correia et al.
ALDH3A2 targets arachidonic acid to promote cell metastasis in TNBC via AMPK/m-TOR signaling pathway [0.03%]
醛脱氢酶3家族成员A2通过AMPK/m-TOR信号通路靶向花生四烯酸促进三阴性乳腺癌细胞转移中文标题
Ding Wang,Shulei Luo,Rongji Yu et al.
Ding Wang et al.
Background: Triple negative breast cancer (TNBC), characterized by its aggressive clinical behavior and propensity for distant metastasis, presents critical challenges in therapeutic management. Emerging evidence implicat...